74 related articles for article (PubMed ID: 23278250)
1. Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human.
Bueters T; Juric S; Sohlenius-Sternbeck AK; Hu Y; Bylund J
Xenobiotica; 2013 Jul; 43(7):607-16. PubMed ID: 23278250
[TBL] [Abstract][Full Text] [Related]
2. Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development.
Karlsson FH; Bouchene S; Hilgendorf C; Dolgos H; Peters SA
Drug Metab Dispos; 2013 Dec; 41(12):2033-46. PubMed ID: 23918667
[TBL] [Abstract][Full Text] [Related]
3. The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans.
Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
J Pharm Sci; 2009 Nov; 98(11):4343-53. PubMed ID: 19230019
[TBL] [Abstract][Full Text] [Related]
4. Presystemic metabolism of AZ'0908, a novel mPGES-1 inhibitor: an in vitro and in vivo cross-species comparison.
Bylund J; Bueters T
J Pharm Sci; 2013 Mar; 102(3):1106-15. PubMed ID: 23316000
[TBL] [Abstract][Full Text] [Related]
5. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs.
Nishimuta H; Nakagawa T; Nomura N; Yabuki M
Xenobiotica; 2013 Nov; 43(11):948-55. PubMed ID: 23593983
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.
Cubitt HE; Houston JB; Galetin A
Drug Metab Dispos; 2011 May; 39(5):864-73. PubMed ID: 21303923
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intestinal metabolism of CYP3A substrates between rats and humans: application of portal-systemic concentration difference method.
Kadono K; Koakutsu A; Naritomi Y; Terashita S; Tabata K; Teramura T
Xenobiotica; 2014 Jun; 44(6):511-21. PubMed ID: 24329478
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
[TBL] [Abstract][Full Text] [Related]
11. Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats.
Berruet N; Sentenac S; Auchere D; Gimenez F; Farinotti R; Fernandez C
J Pharm Pharm Sci; 2005 Aug; 8(2):226-34. PubMed ID: 16124934
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model.
Ruan LP; Chen S; Yu BY; Zhu DN; Cordell GA; Qiu SX
Eur J Med Chem; 2006 May; 41(5):605-10. PubMed ID: 16546303
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
Martignoni M; Groothuis G; de Kanter R
Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
Ireson CR; Jones DJ; Orr S; Coughtrie MW; Boocock DJ; Williams ML; Farmer PB; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):105-11. PubMed ID: 11815407
[TBL] [Abstract][Full Text] [Related]
15. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
17. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.
Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S
Drug Metab Pharmacokinet; 2011 Jun; 26(3):300-6. PubMed ID: 21383522
[TBL] [Abstract][Full Text] [Related]
18. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model.
Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK
Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
20. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements.
Mazur CS; Kenneke JF; Hess-Wilson JK; Lipscomb JC
Drug Metab Dispos; 2010 Dec; 38(12):2232-8. PubMed ID: 20736320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
